financetom
Business
financetom
/
Business
/
Fathom Holdings Q2 revenue beats estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Fathom Holdings Q2 revenue beats estimates
Aug 12, 2025 1:35 PM

Overview

* Fathom Q2 2025 revenue grows 36% yr/yr, beating analyst expectations

* Company returns to adjusted EBITDA profitability in Q2 2025

* Net loss increases due to absence of prior yr's insurance sale gain

Outlook

* Fathom withholds Q3 2025 guidance, plans reassessment in Q4 2025

* Company aims for sustained adjusted EBITDA profitability

* Company expands agent network and ancillary services

Result Drivers

* TRANSACTION GROWTH - 25% increase in real estate transactions primarily driven by addition of My Home Group

* AGENT RECRUITMENT - 23% rise in agent count, supporting transaction growth and platform strength

* ELEVATE PROGRAM - Successful onboarding of agents to Elevate program, enhancing productivity and engagement

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Beat $121.42 $117.30

Revenue mln mln (1

Analyst)

Q2 Net -$3.59

Income mln

Q2 Miss -$3.53 -$2.23

Pretax mln mln (1

Profit Analyst)

Q2 -$2.38

Income mln

from

Operatio

ns

Analyst Coverage

* The one available analyst rating on the shares is "buy"

* The average consensus recommendation for the real estate services peer group is "buy"

* Wall Street's median 12-month price target for Fathom Holdings Inc ( FTHM ) is $1.50, about 9.3% above its August 11 closing price of $1.36

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Premier American Uranium Completes Acquisition of Nuclear Fuels
Premier American Uranium Completes Acquisition of Nuclear Fuels
Sep 16, 2025
TORONTO, Sept. 16, 2025 /PRNewswire/ - Premier American Uranium Inc. ( PAUIF ) (PUR or Premier American Uranium) (TSXV: PUR)  and Nuclear Fuels Inc. ( NFUNF ) (NF or Nuclear Fuels) (CSE: NF) are pleased to announce the completion of the previously announced arrangement (the Arrangement) whereby Premier American Uranium ( PAUIF ) has acquired all of the issued and...
Market Chatter: Eli Lilly's Weight-Loss Pill May Get FDA Approval by Year-End
Market Chatter: Eli Lilly's Weight-Loss Pill May Get FDA Approval by Year-End
Sep 16, 2025
07:43 AM EDT, 09/16/2025 (MT Newswires) -- Eli Lilly's ( LLY ) investigational oral weight-loss drug orforglipron could be approved by the US Food and Drug Administration before the end of the year under a new one-to-two-month priority review process, Reuters reported Tuesday, citing Wall Street analysts. Analysts see the drug as a strong candidate for the fast-track program, which...
The Ether Machine Announces Confidential Submission of a Draft Registration Statement on Form S-4 with the SEC
The Ether Machine Announces Confidential Submission of a Draft Registration Statement on Form S-4 with the SEC
Sep 16, 2025
NEW YORK, Sept. 16, 2025 (GLOBE NEWSWIRE) -- The Ether Machine, a planned public company following a pending business combination with Dynamix Corporation ( ETHM ) (“Dynamix”) and The Ether Reserve LLC, announced today the confidential submission by The Ether Machine of a draft registration statement on Form S-4 with the U.S. Securities and Exchange Commission (the “SEC”).  Andrew Keys,...
Medicines360 acquires global rights to PeriPeach™, advancing new maternal health technology through the 360 Innovation Hub™
Medicines360 acquires global rights to PeriPeach™, advancing new maternal health technology through the 360 Innovation Hub™
Sep 16, 2025
SAN FRANCISCO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Medicines360, a women’s health innovation organization with a mission to be a catalyst for change, today announced that it has acquired global licensing rights to PeriPeach, an investigational medical device designed to prevent severe perineal tears during birth, from Fruits of Labor, Inc. PeriPeach will now advance through the 360 Innovation Hub,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved